Maitreya Medicare (NSE:MAITREYA) Revenue: ₹247.9 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹124.30
View Full Analysis

What is Maitreya Medicare Revenue?

Maitreya Medicare NSE:MAITREYA +1.89% 18 Revenue is ₹247.9 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Maitreya Medicare's revenue for the six months ended in Sep. 2023 was ₹247.9 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹247.9 Mil. Maitreya Medicare's Revenue per Share for the six months ended in Sep. 2023 was ₹36.59. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₹36.59.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Maitreya Medicare  (NSE:MAITREYA) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Maitreya Medicare Revenue Related Terms


Maitreya Medicare Revenue Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Revenue Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Revenue
566.14 494.12 393.80

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Revenue 0.00 0.00 0.00 247.94

NSE:MAITREYA vs HCA, DVA, THC: Revenue Comparison

For the Medical Care Facilities subindustry, Maitreya Medicare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maitreya Medicare Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's Revenue distribution charts can be found below:

* The bar in red indicates where Maitreya Medicare's Revenue falls into.


NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹247.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₹247.9 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Revenue of ₹247.9 Mil as of Sep. 2023. Revenue is the total amount a company generates as sales through its operations. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's Revenue too high?
Maitreya Medicare's current Revenue is ₹247.9 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Revenue compare to HCA and DVA?
Maitreya Medicare's Revenue of ₹247.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Maitreya Medicare and its competitors. Maitreya Medicare's current Revenue is ₹247.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Revenue of ₹247.9 Mil. The current Revenue is ₹247.9 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Revenue is ₹247.9 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹124.30
Price